Neural Regeneration Research ›› 2021, Vol. 16 ›› Issue (1): 99-100.doi: 10.4103/1673-5374.286958

Previous Articles     Next Articles

A novel role for tissue-nonspecific alkaline phosphatase at the blood-brain barrier during sepsis

Divine C. Nwafor, Candice M. Brown*   

  1. Department of Neuroscience, West Virginia University Health Science Center, Morgantown, WV, USA (Nwafor DC, Brown CM)
    Department of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University Health Science Center, Morgantown, WV, USA (Brown CM)
  • Online:2021-01-15 Published:2020-11-23
  • Contact: Candice M. Brown, PhD, cdbrown2@hsc.wvu.edu.
  • Supported by:
    This work was supported by the NIH T32 AG052375 (to DCN), K01 NS081014 (to CMB), West Virginia Clinical and Translational Science Institute (U54 GM104942), and the West Virginia University Stroke CoBRE (P20 GM109098).

Abstract: Sepsis is a life threatening systemic inflammatory condition involving multi-organ dysfunction. The World Health Organization estimates that about 30 million people are affected by sepsis every year, and at least 6 million people die from sepsis each year. Out of approximately 24 million sepsis survivors, it is estimated that 70% of these individuals will experience some form of long-term neurological impairment (Iwashyna et al., 2010). Thus, when combined with prevention, diagnosis, and therapeutic management strategies, a functional understanding of the mechanisms that promote sepsis-associated neurological impairment is necessary to address the clinical challenges and economic burdens faced when treating sepsis.